Literature DB >> 10067853

Pretranslational regulation of rhythmic type II iodothyronine deiodinase expression by beta-adrenergic mechanism in the rat pineal gland.

Y Kamiya1, M Murakami, O Araki, Y Hosoi, T Ogiwara, H Mizuma, M Mori.   

Abstract

It has been demonstrated that type II iodothyronine deiodinase is present in rat pineal gland, and the deiodinase activity markedly increases during the hours of darkness, primarily through beta-adrenergic mechanism. We have studied the relationship between pineal type II iodothyronine deiodinase messenger RNA (mRNA) and the deiodinase activity to elucidate the mechanisms involved in the nocturnal rise in pineal deiodinase activity. Northern analysis has demonstrated that type II iodothyronine deiodinase mRNA is expressed in rat pineal gland, and the mRNA markedly increases during the hours of darkness. The nocturnal increase in pineal type II iodothyronine deiodinase activity is preceded by the increase in its mRNA. Daytime isoproterenol administration resulted in a rapid increase in pineal type II iodothyronine deiodinase mRNA followed by the increase in deiodinase activity. Propranolol treatment, bilateral superior cervical ganglionectomy, or constant light exposure significantly suppressed the nocturnal rise in type II iodothyronine deiodinase mRNA as well as the deiodinase activity. Moreover, isoproterenol or (Bu)2AMP stimulated type II iodothyronine deiodinase mRNA and the deiodinase activity in cultured rat pineal glands. These results suggest that the rhythmic change in pineal type II iodothyronine deiodinase activity is regulated at least in part at the pretranslational level by a beta-adrenergic mechanism transmitted through superior cervical ganglia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067853     DOI: 10.1210/endo.140.3.6594

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Analysis of daily and circadian gene expression in the rat pineal gland.

Authors:  Chiaki Fukuhara; Gianluca Tosini
Journal:  Neurosci Res       Date:  2007-11-06       Impact factor: 3.304

Review 2.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

3.  Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2.

Authors:  M Smith; Z Burke; A Humphries; T Wells; D Klein; D Carter; R Baler
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma.

Authors:  Erika L Souza Meyer; Iuri M Goemann; José Miguel Dora; Marcia S Wagner; Ana Luiza Maia
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

5.  Thyroid hormone activation in vascular smooth muscle cells is negatively regulated by glucocorticoid.

Authors:  Nagaoki Toyoda; Saori Yasuzawa-Amano; Emiko Nomura; Azusa Yamauchi; Kumiko Nishimura; Chizuko Ukita; Satoshi Morimoto; Atsushi Kosaki; Toshiji Iwasaka; John W Harney; P Reed Larsen; Mitsushige Nishikawa
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

Review 6.  Transcriptional regulation of mammalian selenoprotein expression.

Authors:  Zoia R Stoytcheva; Marla J Berry
Journal:  Biochim Biophys Acta       Date:  2009-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.